RIOtrial

The RIO trial is a study of a new type of #HIV treatment, broadly neutralising antibodies, in people diagnosed and treated in early HIV infection.

[RIOtrial @RIOtrial]

To find out more about the #RIOtrial, check out short animated video link below.

https://t.co/sykD9LBtg7

Credits: @HIViBase @AngelinaNamiba @ukcherub @sarahfidler4 @JohnFrater5 Will Everett, Hanna Box

[RIOtrial @RIOtrial]

Next up is Simon Collins @HIViBase who we're very privileged to have been part of the study from the very beginning as a community representative, sharing his insights on the importance of the study as well as community impact towards the study.

[RIOtrial @RIOtrial]

Prof @JohnFrater5 @NDMOxford completing the laboratory journey of the participants' samples, and how we can analyse virology and immunology data in depth from these samples.

[RIOtrial @RIOtrial]

@TTipoe from @NDMOxford explains what happens to the large amounts of blood samples generously donated by #RIOtrial participants.

[RIOtrial @RIOtrial]

It's a celebratory #RIOtrial participant feedback meeting today! As Prof @sarahfidler4 explains, recruitment has completed and we are closer to being able to report the first findings of the study by early next year.

[RIOtrial @RIOtrial]

https://t.co/8SyAJIIjrx

Check out this paper by RIO researcher @TTipoe from @JohnFrater5 lab @NDMOxford.

He reports how HIV-specific T cell responses in people with HIV are impacted by ATIs.

[Ming Lee @jnim87]

https://t.co/DEqoqBlOTX

Pleased to see our meta-analysis of the impact of ATIs and trial interventions eg. #bNAbs, on time to viral resuppression after restarting ART in cure-related studies.

Shoutout to my student Miles Eason @ImperialMed, who drove this work & data collection

[RIOtrial @RIOtrial]

@TTipoe at #AIDS2024 presented on the impact of #ATIs on HIV-specific T cell responses.

[RIOtrial @RIOtrial]

#AIDS2024

@PennyZach1 and @jnim87 present their poster comparing #BNAB sensitivity prediction outcomes using blood or gut proviral DNA and rebound plasma RNA in people treated during primary HIV infection.

[Jillian Lau @JillianLau1]

More #HIVcure posters at #AIDS2024

#bNAb sensitivity
testing in the @RIOtrial of long-acting 3BNC-117 and 10-1074 in PLWHIV started on ART in acute infection. Proviral DNA on ART and plasma RNA at time of viral rebound was tested using NIH or Rockerfeller models.

[Jillian Lau @JillianLau1]

@sarahfidler4 from @imperialcollege starts her talk abt Key Partnerships for #HIVcure research w/ a primer on the contexts & challenges of cure trials, including interrupting treatment in a study.

Sarah is such a clear and articulate speaker, always a joy to watch #AIDS2024

[IAS - the International AIDS Society @iasociety]

▶️ Watch a free replay of our latest #webinar, "Analytical treatment interruptions in #HIV cure research", featuring IAS President @ProfSharonLewin, IAS Governing Council member @jnabukenya88, @Thumbi_Ndungu, @JillianLau1 & other leading voices!

https://t.co/dq7qUsdc9C

[RIOtrial @RIOtrial]

To find out more about the #RIOtrial, visit https://t.co/xKmGUJg2x4

[RIOtrial @RIOtrial]

For those attending #BHIVA24, please check out the poster on understanding participants perspectives around HIV cure-related research involving ATIs in UK, presented by Dr Godakandaarachchi @GSTTnhs

[RIOtrial @RIOtrial]

https://t.co/gmz1DTnylX

@PennyZach1 @JohnFrater5 @NDMOxford report that 29% of a UK cohort of people treated in PHI had predicted resistance to 10-1074 by single genome Env sequence prediction algorithm. This highlights the need for bNAb resistance screening in clinical trials.

[RIOtrial @RIOtrial]

Dr Amanda Clarke and Caroline Cable from @BSUHresearch share their experiences working on the #RIOtrial. @UHSussex is one of our 12 clinical sites participating in the study!

To watch and find out more, visit https://t.co/s2vrITrDUc 🌟💫

[RIOtrial @RIOtrial]

https://t.co/3xfhOcnUWL

Watch Prof Sarah Fidler speak to Ms Louise Terry, a research nurse working on the #RIOtrial, to find out what's it like working on the study.

[RIOtrial @RIOtrial]

People living with HIV were surveyed on their views on joining studies like #RIOtrial which involving temporarily stopping ART (also known as ATIs).

Read the paper by members of the RIO and HEATHER studies here! 🔽

[Ming Lee @jnim87]

Our paper on understanding participants' perspectives around cure-related studies involving analytical treatment interruptions is now out in JVE!

Read it here🔽
https://t.co/WjQEB2Ky06

#HIV #ATI #curestudies

[RIOtrial @RIOtrial]

🎙️https://t.co/YwamUtI5Rv 🎙️

Johan, who is currently participating in the #RIOtrial, kindly agreed to share his experiences and feelings with Prof. Sarah Fidler about pausing antiretroviral therapy (ART) as part of the trial.

Watch the #ParticipantInterview now ⬆️

[Ming Lee @jnim87]

Check out these eposters
at #EACS2023

EP.A.061 attitude towards participation in cure trials which include a TI
EP.A.110 The impact of TIs on viral resuppression
EP.B2.042 Comparing CVS risk models in people living with HIV on modern ART.

[RIOtrial @RIOtrial]

Prof @SarahFidler7 gives an update on treatment interruption trials at #EACS2023